<DOC>
	<DOC>NCT00476723</DOC>
	<brief_summary>The trial will randomise HIV/HBV co-infected individuals to different HBV-active antiretroviral therapy treatment regimens.</brief_summary>
	<brief_title>HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection</brief_title>
	<detailed_description>Longitudinal study of circulating and intra-hepatic HBV-specific T-cell immunity in the setting of a randomised, controlled, international, multi-centre outpatient trial. The trial will randomise HIV/HBV co-infected individuals to different HBV-active antiretroviral therapy treatment regimens. Study population: Patients with HIV/HBV co-infection who are naive to HIV/HBV therapy, have detectable HBV viremia and are willing to start antiretroviral therapy.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Coinfection</mesh_term>
	<criteria>HIV positive hepatitisB coinfected HBV/HIV therapy naive &gt;18 years of age Unable to sign consent form.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>HIV infection</keyword>
	<keyword>Hepatitis coinfection</keyword>
</DOC>